• LG 101506 (RXR Modulator): Precision Tools for RXR Pathway R

  2026-04-25

  LG 101506 delivers reliable RXR modulation for dissecting nuclear receptor signaling in cancer and metabolic studies. This guide details actionable protocols, advanced applications, and troubleshooting strategies, anchored by recent findings in immune checkpoint regulation.

• LG 101506: RXR Modulator-Driven Advances in Cancer Research

  2026-04-24

  LG 101506, a high-purity RXR modulator from APExBIO, empowers researchers to dissect nuclear receptor biology and immune checkpoint regulation with precision. This guide delivers stepwise workflows, actionable protocol enhancements, and troubleshooting insights designed for real-world immuno-oncology and metabolism research.

• Smoothened Agonist (SAG): Precision Tools for Translational

  2026-04-24

  Explore how Smoothened Agonist (SAG) enables next-generation Hedgehog pathway research. This thought-leadership article dissects mechanistic depth, strategic deployment in disease and stem cell models, competitive context, and actionable guidance for translational researchers—anchored by the latest evidence and domain best practices.

• Alda 1: Advanced ALDH2 Activation for Cardiac Regeneration R

  2026-04-23

  Discover how Alda 1, a leading ALDH2 activator, enables cutting-edge cardiac ischemia and regenerative biology research. Explore its unique mechanism, rigorous evidence, and advanced applications beyond standard cell assays.

• Nelfinavir Mesylate: Precision HIV-1 Protease Inhibition in

  2026-04-23

  Explore how Nelfinavir Mesylate, a leading HIV-1 protease inhibitor, enables high-fidelity research from viral suppression to protein homeostasis modulation. This article delivers a uniquely mechanism-centered analysis and protocol insight, advancing beyond standard applications.

• HBsAg Targets TBK1 to Suppress IFN-I and Induce Early Autoph

  2026-04-22

  This study reveals that hepatitis B surface antigen (HBsAg) directly interacts with TANK-binding kinase 1 (TBK1), suppressing type I interferon signaling and inducing early autophagy in hepatocytes. The work uncovers a mechanistic link between viral immune evasion and autophagy dysregulation, offering new insights for antiviral and cancer research.

• 3X (DYKDDDDK) Peptide: Elevating Affinity Purification Workf

  2026-04-22

  The 3X (DYKDDDDK) Peptide sets a new bar for recombinant protein purification, offering enhanced sensitivity and versatility for affinity isolation and immunodetection. Explore protocol-optimized workflows, structural biology use-cases, and actionable troubleshooting strategies that leverage this trimeric epitope tag’s hydrophilic and metal-responsive design.

• D-Lin-MC3-DMA: Precision Design for Immunomodulatory mRNA De

  2026-04-21

  Explore how D-Lin-MC3-DMA, a leading ionizable cationic liposome, powers next-generation mRNA delivery and immunomodulation through machine learning-guided lipid nanoparticle design. Uncover new scientific insights and practical protocols for advanced research.

• SNS-032 (BMS-387032): Protocols for Cancer & Host-Pathogen R

  2026-04-21

  SNS-032 (BMS-387032) delivers precision inhibition of CDK2, CDK7, and CDK9, empowering experimental designs in cancer and emerging antiviral workflows. This article unpacks strategic protocol parameters, cross-domain applications, and troubleshooting tips for maximizing reproducibility and data quality in both oncology and host-targeted virology.

• Rotavirus Downregulates Nrf2 and Host Antioxidant Defenses

  2026-04-20

  This study reveals that progressive rotavirus infection causes a sustained downregulation of the redox-sensitive transcription factor Nrf2 and its downstream antioxidant target genes. The findings provide mechanistic insight into viral manipulation of host redox homeostasis and highlight the complexity of Nrf2 regulation beyond canonical degradation pathways.

• Translational Leverage: Fluorouracil in Solid Tumor Research

  2026-04-20

  This thought-leadership article presents a mechanistic deep dive into Fluorouracil’s action in solid tumor models, contextualized by emerging translational strategies. Bridging foundational biochemistry, competitive evidence, and immune-oncology, it offers actionable guidance for researchers seeking to maximize translational relevance and reproducibility using APExBIO’s Fluorouracil (Adrucil).

• HyperScript™ Reverse Transcriptase: Precision cDNA Synthesis

  2026-04-19

  HyperScript™ Reverse Transcriptase from APExBIO elevates cDNA synthesis reliability—especially for low copy RNA and structured templates, where conventional M-MLV enzymes falter. Its engineered thermal stability and high RNA affinity streamline sensitive workflows for transcriptomics and qPCR.

• AO/PI Staining Solution: Precision in Cell Viability and Inf

  2026-04-18

  Discover how AO/PI Staining Solution leverages advanced fluorescent DNA dyes for unparalleled live/dead cell discrimination. This article uniquely connects fluorescence-based cell counting with mechanistic insights from inflammation and apoptosis research, enabling more informed assay choices.

• Enhanced Colistin-Gamithromycin Activity in Neutropenic Muri

  2026-04-17

  This study demonstrates that combining colistin and gamithromycin significantly improves antimicrobial efficacy against Pasteurella multocida in a neutropenic murine lung infection model. The findings suggest a promising approach to overcoming resistance in high-colistin MIC isolates and optimizing dosing strategies in respiratory disease research.

• SFTSV NSs Disrupts DPP9 Complex to Activate NLRP1 and CARD8

  2026-04-16

  The referenced study uncovers a new mechanism by which SFTSV activates NLRP1 and CARD8 inflammasomes via disruption of the DPP9-mediated ternary complex. This insight advances understanding of viral modulation of innate immunity and informs research on dipeptidyl peptidase inhibitors in inflammation and cancer.

15761 records 1/1051 page Next 12345 下5页 Last page